Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir Bridging Study in Russian HCV Patients
NCT01498068Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2012
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Janssen Pharmaceutical. Started Jan 2012; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01498068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01498068.